Truist Financial Boosts Medical Properties Trust (NYSE:MPW) Price Target to $6.00

Medical Properties Trust (NYSE:MPW) had its target price increased by analysts at Truist Financial from $5.00 to $6.00 in a report released on Friday, Benzinga reports. The brokerage presently has a “hold” rating on the real estate investment trust’s stock. Truist Financial’s price objective points to a potential upside of 6.86% from the company’s previous close.

Other analysts have also recently issued research reports about the stock. BNP Paribas cut shares of Medical Properties Trust from an “outperform” rating to a “neutral” rating and cut their price target for the company from $6.00 to $4.00 in a report on Tuesday, July 2nd. Colliers Securities upgraded shares of Medical Properties Trust from a “neutral” rating to a “buy” rating and set a $6.50 price target on the stock in a report on Friday. Finally, StockNews.com cut shares of Medical Properties Trust from a “hold” rating to a “sell” rating in a report on Saturday, May 18th. Three investment analysts have rated the stock with a sell rating, seven have given a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Hold” and a consensus price target of $5.22.

Medical Properties Trust Stock Up 16.5 %

Shares of Medical Properties Trust stock opened at $5.62 on Friday. The company has a debt-to-equity ratio of 1.51, a quick ratio of 2.93 and a current ratio of 2.93. Medical Properties Trust has a 52-week low of $2.92 and a 52-week high of $6.64. The stock has a market capitalization of $3.37 billion, a price-to-earnings ratio of -2.53, a P/E/G ratio of 0.68 and a beta of 1.28. The company’s 50 day moving average price is $4.69 and its 200-day moving average price is $4.66.

Medical Properties Trust (NYSE:MPW) last issued its earnings results on Thursday, August 8th. The real estate investment trust reported ($0.54) earnings per share (EPS) for the quarter, missing the consensus estimate of $0.21 by ($0.75). The firm had revenue of $266.60 million for the quarter, compared to analysts’ expectations of $259.53 million. The business’s revenue was down 21.0% on a year-over-year basis. During the same quarter last year, the company earned $0.48 EPS. Equities research analysts forecast that Medical Properties Trust will post 0.89 EPS for the current year.

Insider Transactions at Medical Properties Trust

In other Medical Properties Trust news, Director C Reynolds Thompson III sold 20,530 shares of the business’s stock in a transaction dated Tuesday, August 27th. The stock was sold at an average price of $4.38, for a total value of $89,921.40. Following the completion of the transaction, the director now owns 54,637 shares of the company’s stock, valued at approximately $239,310.06. The sale was disclosed in a legal filing with the SEC, which is available through this link. In other Medical Properties Trust news, Director Elizabeth N. Pitman sold 10,025 shares of the business’s stock in a transaction dated Thursday, August 15th. The stock was sold at an average price of $4.98, for a total transaction of $49,924.50. Following the completion of the sale, the director now directly owns 68,653 shares in the company, valued at approximately $341,891.94. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. Also, Director C Reynolds Thompson III sold 20,530 shares of the business’s stock in a transaction dated Tuesday, August 27th. The shares were sold at an average price of $4.38, for a total value of $89,921.40. Following the sale, the director now owns 54,637 shares of the company’s stock, valued at $239,310.06. The disclosure for this sale can be found here. 1.53% of the stock is owned by insiders.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the stock. Vanguard Group Inc. boosted its stake in Medical Properties Trust by 8.2% in the 1st quarter. Vanguard Group Inc. now owns 93,058,174 shares of the real estate investment trust’s stock worth $437,373,000 after purchasing an additional 7,084,981 shares during the period. Charles Schwab Investment Management Inc. boosted its stake in Medical Properties Trust by 5.2% in the 4th quarter. Charles Schwab Investment Management Inc. now owns 9,058,339 shares of the real estate investment trust’s stock worth $44,476,000 after purchasing an additional 448,118 shares during the period. Dimensional Fund Advisors LP boosted its stake in Medical Properties Trust by 4.0% in the 2nd quarter. Dimensional Fund Advisors LP now owns 8,622,683 shares of the real estate investment trust’s stock worth $37,168,000 after purchasing an additional 328,184 shares during the period. Bank of New York Mellon Corp boosted its stake in Medical Properties Trust by 22.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 6,908,362 shares of the real estate investment trust’s stock worth $29,775,000 after purchasing an additional 1,274,481 shares during the period. Finally, Coatue Management LLC boosted its stake in Medical Properties Trust by 18.5% in the 4th quarter. Coatue Management LLC now owns 6,806,501 shares of the real estate investment trust’s stock worth $33,420,000 after purchasing an additional 1,060,830 shares during the period. 71.79% of the stock is currently owned by institutional investors.

Medical Properties Trust Company Profile

Medical Properties Trust, Inc is a self-advised real estate investment trust formed in 2003 to acquire and develop net-leased hospital facilities. From its inception in Birmingham, Alabama, the Company has grown to become one of the world's largest owners of hospital real estate with 441 facilities and approximately 44,000 licensed beds as of September 30, 2023.